On Nov 03, 2025, MED reported earnings of -0.21 USD per share (EPS) for Q3 25, beating the estimate of -0.39 USD, resulting in a 46.69% surprise. Revenue reached 89.41 million, compared to an expected 84.94 million, with a 5.26% difference. The market reacted with a +0.84% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 2 analysts forecast an EPS of -0.82 USD, with revenue projected to reach 74.54 million USD, implying an increase of 290.48% EPS, and decrease of -16.63% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
John B. Sanfilippo & SON
Report Date
Jan 29, 2026 For Q2 26
Estimate
$1.38
Actual
$1.53
Surprise
+10.45%
Sysco Corporation
Report Date
Jan 27, 2026 For Q2 26
Estimate
$0.98
Actual
$0.99
Surprise
+0.38%
McCormick & Company, Incorporated Non-VTG CS
Report Date
Jan 22, 2026 For Q4 25
Estimate
$0.88
Actual
$0.86
Surprise
-2.79%
FAQ
What were Medifast, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Medifast, Inc. reported EPS of -$0.21, beating estimates by 46.69%, and revenue of $89.41M, 5.26% above expectations.
How did the market react to Medifast, Inc.'s Q3 2025 earnings?
The stock price moved up 0.84%, changed from $11.88 before the earnings release to $11.98 the day after.
When is Medifast, Inc. expected to report next?
The next earning report is scheduled for Feb 24, 2026.
What are the forecasts for Medifast, Inc.'s next earnings report?
Based on 2
analysts, Medifast, Inc. is expected to report EPS of -$0.82 and revenue of $74.54M for Q4 2025.